PAREXEL International Early Phase Clinical Unit - Baltimore is a clinical research site located in Baltimore, Maryland, United States 21225.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
PAREXEL International Early Phase Clinical Unit - Baltimore has participated in 1 clinical trials.
Therapeutic areas: Pulmonary Hypertension, Pulmonary Arterial Hypertension.
Sponsors: Aires Pharmaceuticals, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Maryland · View every site in Baltimore
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
PAREXEL International Early Phase Clinical Unit - Baltimore has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
PAREXEL International Early Phase Clinical Unit - Baltimore has 1 clinical trials on record. Their work covers Pulmonary Hypertension, Pulmonary Arterial Hypertension.
PAREXEL International Early Phase Clinical Unit - Baltimore has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.